Daewoong Pharmaceutical has officially launched its botulinum toxin product Nabota in Qatar, further strengthening its ...

Medytox, which opened the era of indigenous botulinum toxin in Korea by developing the first botulinum toxin formulation in Korea, is actively targeting the global market by expanding its product ...

South Korean botulinum toxin makers are going beyond the beauty market and expanding their presence in the therapeutic market as they hope to leverage the rising exports of domestically produced ...

Daewoong Pharmaceutical has launched its botulinum toxin Nabota in Qatar, marking the first Korean-made product of its kind ...

Daewoong Pharmaceutical's high-purity, high-quality botulinum toxin product, 'Nabota,' has successfully entered Qatar, one of the key markets in the Middle East. This marks the first time a domestic p ...

Medytox announced on Dec. 13 that its subsidiary, NEWMECO, has launched a next-generation botulinum toxin product named NEWLUX. NEWMECO received product approval from the Ministry of Food and Drug ...

(Seoul=Yonhap Infomax) Yong Gab Kim – Daewoong Pharmaceutical Co. (069620), a leading South Korean biopharmaceutical company, ...

Daewoong Pharmaceutical’s Nabota has become the first Korean botulinum toxin to enter Qatar, a key Middle Eastern market. With this launch, Nabota has now ente ...

Medytox office Building. [photo=Medytox] Medytox has filed an appeal against the U.S. International Trade Commission’s (ITC) final ruling in its botulinum toxin lawsuit against Hugel. In response, ...